Rossi, Roberta Elisa
Rossi, Roberta Elisa
Dipartimento Scienze Biomediche
A wait-and-watch approach to small pancreatic neuroendocrine tumors : Prognosis and survival
2016-01-01 Massironi, S.; Rossi, R. E.; Zilli, A.; Casazza, G.; Ciafardini, C.; Conte, D.
Adjuvant radiotherapy in urothelial neuroendocrine carcinoma
2020-01-01 Rossi, R. E.; Monteleone, M.; Altomare, M.; Cattaneo, L.; Torchio, M.; Coppa, J.; Mazzaferro, V.
Alpha-Fetoprotein in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Single Centre Study
2018-01-01 Rossi, R; Ciafardini, C; Conte, D; Massironi, S
ALPHA-FETOPROTEIN IN GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS: A SINGLE CENTRE STUDY
2018-01-01 Rossi, R; Ciafardini, C; Conte, D; Massironi, S
An esophageal gastrointestinal stromal tumor in a patient with MEN1-related pancreatic gastrinoma : an unusual association and review of the literature
2014-01-01 Massironi, S.; Rossi, R.; Ferrero, S.; Cavalcoli, F.; Spampatti, M.; Conte, D.; Corbetta, S.; Peracchi, M.
Anti-tumour necrosis factor agent and liver injury : literature review, recommendations for management
2014-01-01 Rossi, R. E.; Parisi, I.; Despott, E. J.; Burroughs, A. K.; O'Beirne, J.; Conte, D.; Hamilton, M. I.; Murray, C. D.
ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors
2018-01-01 Massironi, S.; Rossi, R
ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors
2018-01-01 Massironi, S; Rossi, R
Assessing the effectiveness and safety of surufatinib versus everolimus or sunitinib in advanced neuroendocrine neoplasms: insights from a real-world, retrospective cohort study using propensity score and inverse probability treatment weighting analysis
2024-01-01 Zhu, Linhui; Ye, Xuan; She, Youjun; Liu, Wensheng; Hasegawa, Kiyoshi; Rossi, Roberta Elisa; Du, Qiong; Zhai, Qing
Authorship of Italian medical literature on neuroendocrine neoplasms: any gender gap?
2024-01-01 Rossi, R. E.; La Salvia, A.; Modica, R.; Spada, F.
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study
2020-01-01 Brighi, N; Panzuto, F; Modica, R; Gelsomino, F; Albertelli, M; Pusceddu, S; Massironi, S; Lamberti, G; Rinzivillo, M; Faggiano, A; Spallanzani, A; Ferone, D; Prinzi, N; Rossi, R; Bruno, A; Colao, Am; Campana, D
Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins
2025-01-01 Vitale, G.; Rybinska, I.; Arrivi, G.; Marotta, V.; Di Iasi, G.; Filice, A.; Nardi, C.; Colao, A.; Faggiano, A.; Modica, R.; Benevento, E.; Barrea, L.; La Salvia, A.; Mazzilli, R.; Pandozzi, C.; Pecora, G.; Ruggeri, R. M.; Grossrubatscher, E. M.; Ciocca, E.; Hasballa, I.; Jaafar, S.; Oldani, M.; Rubino, M.; Russo, F.; Peri, A.; Altieri, B.; Aini, I.; Cannavale, G.; Le Moli, L.; Magnelli, C.; Mancini, C.; Zamponi, V.; Lania, A.; Laffi, A.; Di Dato, C.; Detomas, M.; Feola, T.; Lai, R.; Medici, M.; Prinzi, A.; Ferraù, F.; Fanciulli, G.; Capriotti, G.; Di Molfetta, S.; Giorgini, B.; Liccardi, A.; Messina, E.; Sesti, F.; Albertelli, M.; Arecco, A.; Alessi, Y.; Gagliardi, A.; Golisano, B.; Grillo, F.; Prosperi, D.; Vitale, V.; Malandrino, L.; Verrico, M.; Sala, L. D.; Mikovic, N.; Minotta, R.; Prinzi, N.; Tarsitano, M. G.; Giannetta, E.; Guarnotta, V.; De Fata, R.; Laganà, M.; Puliani, G.; Rossi, R.; Veroi, G.
CAN NEUTROPHIL-TO-LYMPHOCYTE RATIO (NLR) PREDICT CLINICAL OUTCOMES OF PANCREATIC NEUROENDOCRINE TUMORS (PanNETs)?
2018-01-01 Massironi, S; Rossi, R; Ciafardini, C; Zilli, A; Cavalcoli, F; Giunta, M; Conte, D
Can Neutrophil-to-Lymphocyte Ratio (NLR) Predict Clinical Outcomes of Pancreatic Neuroendocrine Tumors (PanNETs)?
2018-01-01 Massironi, S; Rossi, R; Ciafardini, C; Zilli, A; Cavalcoli, Fa; Giunta, M; Conte, D
Carcinoid syndrome and hyperinsulinemic hypoglycemia associated with neuroendocrine neoplasms: A critical review on clinical and pharmacological management
2021-01-01 Spada, F.; Rossi, R; Kara, E.; Laffi, A.; Massironi, S.; Rubino, M.; Grimaldi, F.; Bhoori, S.; Fazio, N.
Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour
2014-01-01 Rossi, R; Naik, K.; Navalkissoor, S.; Imber, C.; O'Beirne, J.; Toumpanakis, C.; Caplin, M. E.
Chromogranin A as a Marker in the Follow-up of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs). A Systematic Review
2018-01-01 Rossi, R; Ciafardini, C; Conte, D; Sciola, V; Massironi, S
CHROMOGRANIN A AS A MARKER IN THE FOLLOWUP OF GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NENS). A SYSTEMATIC REVIEW
2018-01-01 Rossi, R; Ciafardini, C; Conte, D; Sciola, V; Massironi, S
Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours
2015-01-01 Rossi, R; Garcia-Hernandez, J.; Meyer, T.; Thirlwell, C.; Watkins, J.; Martin, N. G.; Caplin, M. E.; Toumpanakis, C.
Chromogranin A in diagnosing and monitoring patients with gastro-entero-pancreatic neuroendocrine neoplasms : a large series from a single institution
2014-01-01 Massironi, S.; Rossi, R. E.; Casazza, G.; Conte, D.; Ciafardini, C.; Galeazzi, M.; Peracchi, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A wait-and-watch approach to small pancreatic neuroendocrine tumors : Prognosis and survival | 1-gen-2016 | Massironi, S.; Rossi, R. E.; Zilli, A.; Casazza, G.; Ciafardini, C.; Conte, D. | |
| Adjuvant radiotherapy in urothelial neuroendocrine carcinoma | 1-gen-2020 | Rossi, R. E.; Monteleone, M.; Altomare, M.; Cattaneo, L.; Torchio, M.; Coppa, J.; Mazzaferro, V. | |
| Alpha-Fetoprotein in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Single Centre Study | 1-gen-2018 | Rossi, R; Ciafardini, C; Conte, D; Massironi, S | |
| ALPHA-FETOPROTEIN IN GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS: A SINGLE CENTRE STUDY | 1-gen-2018 | Rossi, R; Ciafardini, C; Conte, D; Massironi, S | |
| An esophageal gastrointestinal stromal tumor in a patient with MEN1-related pancreatic gastrinoma : an unusual association and review of the literature | 1-gen-2014 | Massironi, S.; Rossi, R.; Ferrero, S.; Cavalcoli, F.; Spampatti, M.; Conte, D.; Corbetta, S.; Peracchi, M. | |
| Anti-tumour necrosis factor agent and liver injury : literature review, recommendations for management | 1-gen-2014 | Rossi, R. E.; Parisi, I.; Despott, E. J.; Burroughs, A. K.; O'Beirne, J.; Conte, D.; Hamilton, M. I.; Murray, C. D. | |
| ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors | 1-gen-2018 | Massironi, S.; Rossi, R | |
| ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors | 1-gen-2018 | Massironi, S; Rossi, R | |
| Assessing the effectiveness and safety of surufatinib versus everolimus or sunitinib in advanced neuroendocrine neoplasms: insights from a real-world, retrospective cohort study using propensity score and inverse probability treatment weighting analysis | 1-gen-2024 | Zhu, Linhui; Ye, Xuan; She, Youjun; Liu, Wensheng; Hasegawa, Kiyoshi; Rossi, Roberta Elisa; Du, Qiong; Zhai, Qing | |
| Authorship of Italian medical literature on neuroendocrine neoplasms: any gender gap? | 1-gen-2024 | Rossi, R. E.; La Salvia, A.; Modica, R.; Spada, F. | |
| Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study | 1-gen-2020 | Brighi, N; Panzuto, F; Modica, R; Gelsomino, F; Albertelli, M; Pusceddu, S; Massironi, S; Lamberti, G; Rinzivillo, M; Faggiano, A; Spallanzani, A; Ferone, D; Prinzi, N; Rossi, R; Bruno, A; Colao, Am; Campana, D | |
| Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins | 1-gen-2025 | Vitale, G.; Rybinska, I.; Arrivi, G.; Marotta, V.; Di Iasi, G.; Filice, A.; Nardi, C.; Colao, A.; Faggiano, A.; Modica, R.; Benevento, E.; Barrea, L.; La Salvia, A.; Mazzilli, R.; Pandozzi, C.; Pecora, G.; Ruggeri, R. M.; Grossrubatscher, E. M.; Ciocca, E.; Hasballa, I.; Jaafar, S.; Oldani, M.; Rubino, M.; Russo, F.; Peri, A.; Altieri, B.; Aini, I.; Cannavale, G.; Le Moli, L.; Magnelli, C.; Mancini, C.; Zamponi, V.; Lania, A.; Laffi, A.; Di Dato, C.; Detomas, M.; Feola, T.; Lai, R.; Medici, M.; Prinzi, A.; Ferraù, F.; Fanciulli, G.; Capriotti, G.; Di Molfetta, S.; Giorgini, B.; Liccardi, A.; Messina, E.; Sesti, F.; Albertelli, M.; Arecco, A.; Alessi, Y.; Gagliardi, A.; Golisano, B.; Grillo, F.; Prosperi, D.; Vitale, V.; Malandrino, L.; Verrico, M.; Sala, L. D.; Mikovic, N.; Minotta, R.; Prinzi, N.; Tarsitano, M. G.; Giannetta, E.; Guarnotta, V.; De Fata, R.; Laganà, M.; Puliani, G.; Rossi, R.; Veroi, G. | |
| CAN NEUTROPHIL-TO-LYMPHOCYTE RATIO (NLR) PREDICT CLINICAL OUTCOMES OF PANCREATIC NEUROENDOCRINE TUMORS (PanNETs)? | 1-gen-2018 | Massironi, S; Rossi, R; Ciafardini, C; Zilli, A; Cavalcoli, F; Giunta, M; Conte, D | |
| Can Neutrophil-to-Lymphocyte Ratio (NLR) Predict Clinical Outcomes of Pancreatic Neuroendocrine Tumors (PanNETs)? | 1-gen-2018 | Massironi, S; Rossi, R; Ciafardini, C; Zilli, A; Cavalcoli, Fa; Giunta, M; Conte, D | |
| Carcinoid syndrome and hyperinsulinemic hypoglycemia associated with neuroendocrine neoplasms: A critical review on clinical and pharmacological management | 1-gen-2021 | Spada, F.; Rossi, R; Kara, E.; Laffi, A.; Massironi, S.; Rubino, M.; Grimaldi, F.; Bhoori, S.; Fazio, N. | |
| Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour | 1-gen-2014 | Rossi, R; Naik, K.; Navalkissoor, S.; Imber, C.; O'Beirne, J.; Toumpanakis, C.; Caplin, M. E. | |
| Chromogranin A as a Marker in the Follow-up of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs). A Systematic Review | 1-gen-2018 | Rossi, R; Ciafardini, C; Conte, D; Sciola, V; Massironi, S | |
| CHROMOGRANIN A AS A MARKER IN THE FOLLOWUP OF GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NENS). A SYSTEMATIC REVIEW | 1-gen-2018 | Rossi, R; Ciafardini, C; Conte, D; Sciola, V; Massironi, S | |
| Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours | 1-gen-2015 | Rossi, R; Garcia-Hernandez, J.; Meyer, T.; Thirlwell, C.; Watkins, J.; Martin, N. G.; Caplin, M. E.; Toumpanakis, C. | |
| Chromogranin A in diagnosing and monitoring patients with gastro-entero-pancreatic neuroendocrine neoplasms : a large series from a single institution | 1-gen-2014 | Massironi, S.; Rossi, R. E.; Casazza, G.; Conte, D.; Ciafardini, C.; Galeazzi, M.; Peracchi, M. |